levamisole has been researched along with Di Guglielmo Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuksina, I; Hellinger, N; Scher, BM; Scher, W; Waxman, S | 1 |
| Scher, BM; Scher, W; Waxman, S; Wei, XJ | 1 |
2 other study(ies) available for levamisole and Di Guglielmo Disease
| Article | Year |
|---|---|
The phosphatase inhibitors, orthovanadate and levamisole, inhibit induction of erythroid differentiation and abrogate the associated inhibition of glycolysis.
Topics: Animals; Cell Differentiation; Dimethyl Sulfoxide; Erythropoiesis; Fructosediphosphates; Glycolysis; Kinetics; Lactates; Leukemia, Erythroblastic, Acute; Levamisole; Mice; Models, Biological; Protein Tyrosine Phosphatases; Signal Transduction; Suramin; Tetramisole; Tumor Cells, Cultured; Vanadates | 1998 |
Dephosphorylation of Vav is associated with the induction of mouse erythroleukemia cell differentiation: effects of orthovanadate and levamisole.
Topics: Acetamides; Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cell Differentiation; Leukemia, Erythroblastic, Acute; Levamisole; Mice; Oncogene Proteins; Phosphorylation; Proteins; Proto-Oncogene Proteins c-vav; Receptors, Erythropoietin; Tumor Cells, Cultured; Vanadates | 1998 |